These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1625719)

  • 21. ATRA syndrome with extensive organ infiltration.
    Kakkar N; Dhameja N; Jasmina ; Das A; Radotra BD; Varma S
    Am J Hematol; 2002 Sep; 71(1):62-4. PubMed ID: 12221682
    [No Abstract]   [Full Text] [Related]  

  • 22. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia.
    Parma M; Casaroli I; Pogliani EM
    Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387
    [No Abstract]   [Full Text] [Related]  

  • 23. Scrotal ulcerations during all-transretinoic acid therapy for acute promyelocytic leukemia.
    Ramzi J; Hend BN; Lamia A; Raihane BL; Hela BA; Zaher BA; Balkis M
    Ann Hematol; 2007 Apr; 86(4):289-90. PubMed ID: 17205289
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
    Gallipoli P; Drummond MW
    Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
    [No Abstract]   [Full Text] [Related]  

  • 25. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 26. Complications of therapy in cancer patients: Case 2. Scrotal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia.
    Gettinger S; Shapira I; Scheinfeld N; Grossbard M
    J Clin Oncol; 2004 Nov; 22(22):4648-9. PubMed ID: 15542816
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental model for differentiation therapy of leukemia].
    Hayashi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 29. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L
    J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-trans retinoic acid-induced labor in a pregnant patient with acute promyelocytic leukemia.
    Sham RL
    Am J Hematol; 1996 Oct; 53(2):145. PubMed ID: 8892746
    [No Abstract]   [Full Text] [Related]  

  • 31. Retinoic acid and arsenic for treating acute promyelocytic leukemia.
    Zhou GB; Zhao WL; Wang ZY; Chen SJ; Chen Z
    PLoS Med; 2005 Jan; 2(1):e12. PubMed ID: 15696202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-trans retinoic acid related headache in patients with acute promyelocytic leukemia: prophylaxis and treatment with acetazolamide.
    Ganguly S
    Leuk Res; 2005 Jun; 29(6):721. PubMed ID: 15863216
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of malignant hemopathies with all transretinoic acid].
    Fenaux P; Chomienne C
    Presse Med; 1997 Oct; 26(29):1399-405. PubMed ID: 9404351
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary relapse of acute promyelocytic leukemia after ATRA.
    Lugassy G; Halperin Y
    Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
    [No Abstract]   [Full Text] [Related]  

  • 36. All-trans-retinoic acid therapy.
    Wong KF
    Br J Haematol; 2010 May; 149(3):309. PubMed ID: 20064161
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
    Castaigne S
    Soins; 1990; (538-539):24-6. PubMed ID: 2237532
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiation therapy for acute promyelocytic leukemia.
    Fenaux P; Degos L
    N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia.
    Manna A; Cadenotti L; Motto A; Ballo P
    Ann Hematol; 2009 Jan; 88(1):91-2. PubMed ID: 18633613
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship between the levels of granulocyte colony-stimulating factor and leukocytosis induced by all-trans retinoic acid in acute promyelocytic leukemia.
    Wu W; Sun G; Wu W; Zhou R; Li X; Shen Z; Wang Z
    Chin Med J (Engl); 1999 Dec; 112(12):1085-7. PubMed ID: 11721444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.